#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4052329	B	Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs followed by substrate addition measured every 2 mins for 1 hr by amplex red reagent-based fluorescence assay	Homo sapiens	30		cell-based format	Scientific Literature
2.	ALA4052332	B	Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs followed by substrate addition in presence of 0.1% BSA measured every 2 mins for 1 hr by amplex red reagent-based fluorescence assay	Homo sapiens	30		cell-based format	Scientific Literature
3.	ALA4052333	B	Inhibition of human LOX expressed in HEK cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs followed by substrate addition in presence of 0.1% BSA measured every 2 mins for 1 hr by amplex red reagent-based fluorescence assay	Homo sapiens	30		cell-based format	Scientific Literature
4.	ALA4052334	B	Inhibition of recombinant human LOXL2 expressed in human whole blood assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs followed by substrate addition measured every 2 mins for 1 hr by amplex red reagent-based fluorescence assay	Homo sapiens	30		assay format	Scientific Literature
5.	ALA4052335	A	Cmax in C57BL/6 mouse lung at 30 mg/kg, po by LC-MS/MS analysis	Mus musculus	12		organism-based format	Scientific Literature
6.	ALA4052336	A	Cmax in C57BL/6 mouse plasma at 30 mg/kg, po by LC-MS/MS analysis	Mus musculus	12		organism-based format	Scientific Literature
7.	ALA4052343	B	Irreversible inhibition of human LOXL2 assessed as reduction of H2O2 production from oxidative deamination of DAP at 1000 times IC50 preincubated for 2 hrs followed by compound washout and subsequent incubation for 2 hrs prior to substrate addition measured every 2 mins for 40 mins by amplex red reagent-based fluorescence assay relative to control	Homo sapiens	10		single protein format	Scientific Literature
8.	ALA4052344	B	Irreversible inhibition of human LOXL2 assessed as catalytic activity preincubated for 2 hrs followed by substrate addition measured every 2 mins for 1 hr by amplex red reagent-based fluorescence assay relative to control	Homo sapiens	10		single protein format	Scientific Literature
9.	ALA4418378	B	Inhibition of human LOXL2 expressed in CHO cells assessed as reduction in amine oxidase activity incubated for 2 hrs by Amplex red based fluorescence assay	Homo sapiens	120		cell-based format	Patent Bioactivity Data
10.	ALA4418379	F	Antifibrotic activity in C57BL/6 mouse model of bleomycin-induced lung fibrosis assessed as reduction in collagen level in lung at 60 mg/kg, po pre-treated 1 hr to 1 day before bleomycin injection and measured after 14 to 28 days by hydroxyproline assay	Mus musculus	6		organism-based format	Patent Bioactivity Data
11.	ALA4418380	F	Antifibrotic activity in C57BL/6 mouse model of bleomycin-induced lung fibrosis assessed as reduction in cross linked collagen level in lung at 60 mg/kg, po pre-treated 1 hr to 1 day before bleomycin injection and measured after 14 to 28 days by Masson's trichrome staining based assay	Mus musculus	6		organism-based format	Patent Bioactivity Data
12.	ALA4418381	F	Antifibrotic activity in C57BL/6 mouse model of bleomycin-induced lung fibrosis assessed as reduction in cross linked collagen level in lung at 60 mg/kg, po pre-treated 1 hr to 1 day before bleomycin injection and measured after 14 to 28 days by Picro-Sirius staining based assay	Mus musculus	6		organism-based format	Patent Bioactivity Data
13.	ALA4418382	F	Antifibrotic activity in C57BL/6 mouse model of bleomycin-induced lung fibrosis assessed as reduction in alpha smooth muscle actin level in lung at 60 mg/kg, po pre-treated 1 hr to 1 day before bleomycin injection and measured after 14 to 28 days by immunohistochemistry analysis	Mus musculus	6		organism-based format	Patent Bioactivity Data
14.	ALA4418383	F	Antifibrotic activity in C57BL/6 mouse model of bleomycin-induced lung fibrosis assessed as reduction in hydroxyproline in lung homogenates at 60 mg/kg, po pre-treated 1 hr to 1 day before bleomycin injection and measured after 14 to 28 days by chloramine T and Erlich's solution based assay	Mus musculus	6		organism-based format	Patent Bioactivity Data